PNA Medical Corner July 2020

 

Dr. Maria Fleseriu on Pituitary Disease and COVID-19

FlesiriuThis month the PNA Medical Corner showcases a paper co-written by Dr. Maria Fleseriu, a neurosurgeon at Oregon Health and Science University and a member of the PNA. The paper, published in the journal Pituitary, gives guidance on the management of pituitary disease during the COVID pandemic. She advises clinicians to consider local conditions when deciding between medical and surgical treatments, because the novel coronavirus has reduced access to testing necessary for surgical care. Read more:
https://link.springer.com/article/10.1007/s11102-020-01059-7
Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic—an international perspective
• Maria Fleseriu,
• Michael Buchfelder,
• Justin S. Cetas,
• Pouneh K. Fazeli,
• Susana M. Mallea-Gil,
• Mark Gurnell,
• Ann McCormack,
• Maria M. Pineyro,
• Luis V. Syro,
• Nicholas A. Tritos &
• Hani J. Marcus
Pituitary volume 23, pages327–337(2020)Cite this article
• 910 Accesses
• 26 Altmetric
• Metrics details


Abstract

 
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the viral strain that has caused the coronavirus disease 2019 (COVID-19) pandemic, has presented healthcare systems around the world with an unprecedented challenge.

In locations with significant rates of viral transmission, social distancing measures and enforced ‘lockdowns’ are the new ‘norm’ as governments try to prevent healthcare services from being overwhelmed. However, with these measures have come important challenges for the delivery of existing services for other diseases and conditions. The clinical care of patients with pituitary disorders typically involves a multidisciplinary team, working in concert to deliver timely, often complex, disease investigation and management, including pituitary surgery. COVID-19 has brought about major disruption to such services, limiting access to care and opportunities for testing (both laboratory and radiological), and dramatically reducing the ability to safely undertake transsphenoidal surgery. In the absence of clinical trials to guide management of patients with pituitary disease during the COVID-19 pandemic, herein the Professional Education Committee of the Pituitary Society proposes guidance for continued safe management and care of this population.

 

*

The news site Healio also published an article about this research: https://www.healio.com/news/endocrinology/20200625/guidance-for-pituitary-disease-management-during-covid19

 

Print